NYSE$ATR

AptarGroup Inc. · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

AptarGroup's Q3 2020 results reflected an increase in sales and core sales, driven by the Pharma segment and growth in food, personal care, and home care markets, while beauty and beverage markets were impacted by COVID-19.

AptarGroup reported an 8% increase in sales to $759 million with a 2% increase in core sales during Q3 2020. The Pharma segment showed strong growth, while Beauty and Beverage segments were impacted by COVID-19. Earnings per share increased to $0.95, and adjusted earnings per share rose to $1.00.

  • Reported sales increased 8%, including positive effects of currency translation rates and recent acquisitions, and core sales increased 2%.
  • Strong reported and core growth in the Pharma segment.
  • Core sales growth in the food, personal care and home care markets.
  • Reported earnings per share totaled $0.95 (an increase of 12% compared to the prior year), and adjusted earnings per share totaled $1.00 (an increase of 3% compared to the prior year).

Headline financials

Total Revenue

$759M

Previous: $701M+8.3%
EPS (adj)

$1.00

Previous: $0.93+7.5%
Total Core Sales Growth

2.0%

No prior period
Pharma Core Sales Growth

11.0%

No prior period
Capital Expenditures

-$173M

Previous: -$187M+7.2%
Free Cash Flow

-$110M

Previous: -$130M+15.7%
Net Income

$63.7M

Previous: $56.8M+12.3%
Operating Income

$99M

Previous: $90.2M+9.7%
Gross Profit

$759M

Previous: $701M+8.3%
Cash & Equivalents

$227M

Previous: $271M-16.3%
Total Assets

$3.86B

Previous: $3.47B+11.4%
Stock-Based Comp

$8.59M

Previous: $5.1M+68.5%

Revenue & EPS history

AptarGroup · Revenue · Quarterly

$759M

Q3 2020+8.3%vs Q3 2019
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

AptarGroup · $759M total across 3 segments · Q3 2020

  • Beauty
    $337M
  • Pharma
    $316M
  • Closures
    $106M

Forward guidance

Aptar expects to continue to achieve core sales growth in the fourth quarter, with rising demand in many end markets expected to more than offset COVID-19 related declines in some other end markets. Aptar expects earnings per share for the fourth quarter of 2020, excluding any restructuring expenses and acquisition-related costs, to be in the range of $0.84 to $0.92.

Tailwinds

  • Company expects to continue to achieve core sales growth in the fourth quarter.
  • Rising demand in many end markets is expected to more than offset COVID-19 related declines in some of our other end markets.
  • Company is proud of the way our employees have responded to the difficult year and we are performing well.
  • Company expects our Pharma business to continue to do well with existing business
  • Company expects increased opportunities directly and indirectly related to the pandemic

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

+0.3%

Avg return

Earnings day

-0.1%

Avg return

5 days after

+1.2%

Avg return

30 days after

63%

43 / 68 earnings

Positive

+9.2%

Q4 2017

Best reaction

-9.0%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.3%-0.8%-6.4%
Q4 2025+8.3%+12.9%+6.5%
Q3 2025-9.0%-7.1%+0.3%
Q1 2025+2.3%+2.1%+6.8%
Q4 2024-8.5%-9.4%-2.3%
Q3 2024+0.8%+0.6%+2.3%
Q2 2024+1.7%+1.1%+4.4%
Q1 2024+2.4%+3.1%+5.8%
Q4 2023+5.4%+3.1%+8.6%
Q3 2023+0.1%-0.9%+4.2%
Q2 2023+3.2%+2.1%+6.3%
Q1 2023+2.4%+4.1%-1.4%
Q4 2022+5.7%+4.2%+0.3%
Q3 2022+2.1%-1.9%+6.9%
Q2 2022+1.6%+0.5%-1.5%
Q1 2022+3.4%+2.5%-2.0%
Q4 2021+3.3%+3.8%+2.7%
Q3 2021-3.6%+1.7%+1.0%
Q2 2021-6.3%-6.6%-2.3%
Q1 2021-0.2%+2.6%-2.5%
Q4 2020-7.7%-10.4%-2.7%
Q3 2020+1.6%+6.4%+13.3%
Q2 2020-3.0%-0.2%-0.6%
Q1 2020-3.6%-4.1%+1.2%
Q4 2019-2.6%-7.0%-19.6%
Q3 2019-7.1%-8.9%-6.0%
Q2 2019-5.0%-5.4%-1.3%
Q1 2019+1.3%+2.3%+2.0%
Q4 2018+1.5%+0.0%+2.2%
Q3 2018+1.8%+2.1%+2.0%
Q2 2018+8.6%+8.1%+9.6%
Q1 2018+0.3%+0.4%+1.0%
Q4 2017+9.2%+11.8%+9.6%
Q3 2017-0.6%-1.6%-2.5%
Q2 2017-6.5%-6.3%-6.4%
Q1 2017+1.2%+1.1%+6.3%
Q4 2016+1.7%+0.4%+4.4%
Q3 2016-4.3%-7.4%-0.3%
Q2 2016-1.9%-3.9%-1.6%
Q1 2016-3.1%
Q4 2015-2.8%
Q3 2015+2.4%
Q2 2015+8.3%
Q1 2015+2.4%
Q4 2014+1.8%
Q3 2014+2.0%
Q2 2014-3.5%
Q1 2014-0.1%
Q4 2013+1.9%
Q3 2013+0.2%
Q2 2013-2.1%
Q1 2013-2.0%
Q4 2012-0.8%
Q3 2012-3.5%
Q2 2012+2.6%
Q1 2012+0.9%
Q4 2011+0.1%
Q3 2011+5.8%
Q2 2011-5.0%
Q1 2010+2.2%
Q1 2011+2.3%
Q4 2008+1.5%
Q4 2010+1.5%
Q3 2010+2.9%
Q3 2009+2.9%
Q4 2009+0.5%
Q2 2009+0.5%
Q2 2010+0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro